Scholarlink

Background <p>Acute kidney injury (AKI) is a common complication in patients affected by&#xa0;COVID-19 and has been strongly associated with increased mortality. However, its independent contribution remains debated. This study aimed to evaluate the independent association using a directed acyclic graph-based approach.</p> Methods <p>Retrospective, multicenter cohort study in Medellín, Colombia, from June 2020 to April 2022. AKI was defined according to KDIGO criteria. A directed acyclic graph was constructed to map the hypothesized causal relationship between AKI and mortality, integrating evidence from a comprehensive literature review and expert´s consensus. A Poisson regression model with robust variance was applied to estimate adjusted incidence rate ratios (IRRs) for mortality.</p> Results <p>A total of 1722 patients were included, of whom 30.7% developed AKI. Mortality was higher among patients with AKI (58.1% vs. 19.6%). A directed acyclic graph was used to identify a minimal sufficient adjustment set for confounding control. After adjustment, the IRRs for in-hospital mortality were 1.25 (95% CI: 1.09–1.43) for stage 1, 1.62 (95% CI: 1.35–1.93) for stage 2, and 1.64 (95% CI: 1.46–1.85) for stage 3.</p> Conclusions <p>AKI is independently and significantly associated with an increased risk of mortality in COVID-19 patients. This study makes a novel contribution by applying directed acyclic graphs to enhance causal inference. Directed acyclic graphs provide a rigorous framework for identifying true confounders and avoiding inappropriate adjustment for mediators, thereby reducing bias and improving the validity of causal estimates. In clinical settings where randomized controlled trials are not feasible, the use of directed acyclic graphs represents a robust alternative for exploring causal relationships.</p> Graphical abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Acute kidney injury and in-hospital mortality in COVID-19: a causal analysis using directed acyclic graphs

  • 期刊论文

  • 发表日期：

    2025年9月8日

查看全文
  • Paola Andrea Gallego Aristizabal,
  • Tania Paola Lujan Chavarría,
  • Joaquín Rodelo-Ceballos,
  • Sara Botero Bolívar,
  • Sara Isabel Vergara Hernández,
  • Isabella Rocha Giraldo,
  • Cristian Fernando Marcillo Calderón,
  • Ana María Londoño Giraldo,
  • Federico Rincon Acosta ,
  • María Paula Sanchez Carmona,
  • Paula Andrea Salazar Ospina,
  • Fabián Jaimes

摘要

Background

Acute kidney injury (AKI) is a common complication in patients affected by COVID-19 and has been strongly associated with increased mortality. However, its independent contribution remains debated. This study aimed to evaluate the independent association using a directed acyclic graph-based approach.

Methods

Retrospective, multicenter cohort study in Medellín, Colombia, from June 2020 to April 2022. AKI was defined according to KDIGO criteria. A directed acyclic graph was constructed to map the hypothesized causal relationship between AKI and mortality, integrating evidence from a comprehensive literature review and expert´s consensus. A Poisson regression model with robust variance was applied to estimate adjusted incidence rate ratios (IRRs) for mortality.

Results

A total of 1722 patients were included, of whom 30.7% developed AKI. Mortality was higher among patients with AKI (58.1% vs. 19.6%). A directed acyclic graph was used to identify a minimal sufficient adjustment set for confounding control. After adjustment, the IRRs for in-hospital mortality were 1.25 (95% CI: 1.09–1.43) for stage 1, 1.62 (95% CI: 1.35–1.93) for stage 2, and 1.64 (95% CI: 1.46–1.85) for stage 3.

Conclusions

AKI is independently and significantly associated with an increased risk of mortality in COVID-19 patients. This study makes a novel contribution by applying directed acyclic graphs to enhance causal inference. Directed acyclic graphs provide a rigorous framework for identifying true confounders and avoiding inappropriate adjustment for mediators, thereby reducing bias and improving the validity of causal estimates. In clinical settings where randomized controlled trials are not feasible, the use of directed acyclic graphs represents a robust alternative for exploring causal relationships.

Graphical abstract